NCT00544284View on ClinicalTrials.gov

Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Brain and Central Nervous System TumorsLymphomaMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

bortezomib

DRUG

temozolomide

OTHER

pharmacological study

Trial Locations (2)

91105

City of Hope Medical Group, Pasadena

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00544284 - Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment | Biotech Hunter | Biotech Hunter